Abstract
A new series of bisindole based sulfonates (4a-t) have been synthesized and evaluated for their anticancer activity against various human cancer cell lines. Some of these compounds exhibited good inhibitory activity against most of the cell lines tested. Interestingly all the compounds from the bisindole sulfonate series exhibited selective inhibition against MCF-7 cell line. Further these compounds have also been tested for their inhibition of tubulin polymerization. The compounds 4a, 4l, 4n, 4r and 4t demonstrated a dose dependent tubulin inhibition with IC50 values of 2.3, 1.7, 8.1, 6.0 and 10 μM, respectively. Thus, results have demonstrated that antiproliferative activity of these compounds is related to their inhibition of tubulin polymerization.
Keywords: Anticancer activity, Indoles, Sulfonates, Tubulin polymerization, Bisindole Sulfonates, cyclin-dependent kinases (CDKs), antiangiogenic, heterocyclic ring system, indole, mitomycin, cytotoxicity, Micro mass, Column chromatography
Letters in Drug Design & Discovery
Title: Synthesis, Anticancer Activity and Inhibition of Tubulin Polymerization of Bisindole Sulfonates
Volume: 9 Issue: 3
Author(s): Ahmed Kamal, Y. V.V. Srikanth, M. Naseer Ahmed Khan, Md. Ashraf, Thokhir Basha Shaik and Shasi V. Kalivendi
Affiliation:
Keywords: Anticancer activity, Indoles, Sulfonates, Tubulin polymerization, Bisindole Sulfonates, cyclin-dependent kinases (CDKs), antiangiogenic, heterocyclic ring system, indole, mitomycin, cytotoxicity, Micro mass, Column chromatography
Abstract: A new series of bisindole based sulfonates (4a-t) have been synthesized and evaluated for their anticancer activity against various human cancer cell lines. Some of these compounds exhibited good inhibitory activity against most of the cell lines tested. Interestingly all the compounds from the bisindole sulfonate series exhibited selective inhibition against MCF-7 cell line. Further these compounds have also been tested for their inhibition of tubulin polymerization. The compounds 4a, 4l, 4n, 4r and 4t demonstrated a dose dependent tubulin inhibition with IC50 values of 2.3, 1.7, 8.1, 6.0 and 10 μM, respectively. Thus, results have demonstrated that antiproliferative activity of these compounds is related to their inhibition of tubulin polymerization.
Export Options
About this article
Cite this article as:
Kamal Ahmed, V.V. Srikanth Y., Naseer Ahmed Khan M., Ashraf Md., Basha Shaik Thokhir and V. Kalivendi Shasi, Synthesis, Anticancer Activity and Inhibition of Tubulin Polymerization of Bisindole Sulfonates, Letters in Drug Design & Discovery 2012; 9 (3) . https://dx.doi.org/10.2174/157018012799129774
DOI https://dx.doi.org/10.2174/157018012799129774 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanoparticles: Properties and Applications in Cancer Immunotherapy
Current Pharmaceutical Design Epidermal Stem Cells - Role in Normal, Wounded and Pathological Psoriatic and Cancer Skin
Current Stem Cell Research & Therapy Incremental Value of Two Dimensional Speckle Tracking Echocardiography in the Functional Assessment and Characterization of Subclinical Left Ventricular Dysfunction
Current Cardiology Reviews The Gut Mucosa as a Site for Induction of Regulatory T-Cells
Current Pharmaceutical Design Multiple Forms of Proteasomes and their Role in Tumor Fate
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review
Current Drug Metabolism Role of Nuclear Steroid Receptors in Apoptosis
Current Medicinal Chemistry A Dual Mode Pulsed Electro-Magnetic Cell Stimulator Produces Acceleration of Myogenic Differentiation
Recent Patents on Biotechnology IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
Current Rheumatology Reviews Fused hydrophobic elastin-like-peptides (ELP) enhance biological activity of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
Protein & Peptide Letters Structural and Functional Characterization of the Proteins Responsible for N<sup>6</sup>-Methyladenosine Modification and Recognition
Current Protein & Peptide Science The Stem Cell Factor Receptor/c-Kit as a Drug Target in Cancer
Current Cancer Drug Targets Temozolomide: An Update on Pharmacological Strategies to Increase its Antitumour Activity
Medicinal Chemistry Reviews - Online (Discontinued) Role of Prolyl Isomerase Pin1 in Pathogenesis of Diseases and Remedy for the Diseases from Natural Products
Current Drug Targets Protein-protein Interactions: Network Analysis and Applications in Drug Discovery
Current Pharmaceutical Design Molecule of the Month
Current Topics in Medicinal Chemistry Imaging of Spinal Bone Tumors: Principles and Practice
Current Medical Imaging Oncolytic Virus Therapy - Foreword
Current Cancer Drug Targets SHP2 Inhibition Benefits Epidermal Growth Factor Receptor-mutated Non-Small Cell Lung Cancer Therapy
Mini-Reviews in Medicinal Chemistry Is it Possible to Reduce the Incident of Colorectal Cancer by Modifying Diet and Lifestyle?
Current Cancer Therapy Reviews